FAECAL CALPROTECTIN

PTH-092 Clinical validity and utility of faecal calprotectin in primary care
GJ Walker, L Moore, N Heerasing, PJ Hendy, C Bewshea, JR Goodhand, NA Kennedy, C Calvert, T Ahmad

Gut Jul 2017, 66 (Suppl 2) A252; DOI: 10.1136/gutjnl-2017-314472.491
PTU-061 Determining a value of faecal calprotectin above which colonoscopy is indicated in the county durham and darlington population
R Dunn, D Kejariwal, I Malik, O Ogunrinde, A Kannan, S Farook

Gut Jul 2017, 66 (Suppl 2) A80-A81; DOI: 10.1136/gutjnl-2017-314472.156
PTU-130 Indeterminate faecal calprotectin identifies significant small bowel crohn’s disease
A Kumar, B Hicken, A Milestone, R Ransford

Gut Jul 2017, 66 (Suppl 2) A114-A115; DOI: 10.1136/gutjnl-2017-314472.225
PTU-131 Are faecal calprotectin and radiological imaging reliable investigations in predicting small bowel crohn’s disease?
A Kumar, B Hicken, A Milestone, A Ahmed, R Ransford

Gut Jul 2017, 66 (Suppl 2) A115; DOI: 10.1136/gutjnl-2017-314472.226
PWE-065 Patients’ perception of faecal calprotectin testing in inflammatory bowel disease: results from a prospective patient based survey
R Kalla, B Crooks, V Hall, S Tatersall, Z Ndlovu, A Simon, K Moriarty, G Lipscomb, S Singh

Gut Jul 2017, 66 (Suppl 2) A158-A159; DOI: 10.1136/gutjnl-2017-314472.311
PTH-069 Is a false positive faecal calprotectin as false as you think ?
L Asser, S Nanton, T Price, H Holt, MW Johnson

Gut Jul 2017, 66 (Suppl 2) A240-A242; DOI: 10.1136/gutjnl-2017-314472.468
OC-057 Undetectable faecal immunochemical test for haemoglobin excludes colorectal cancer in symptomatic patients: a prospective uk study
MM Widlak, CL Thomas, MG Thomas, C Tomkins, S Smith, C Darby, N O’Connell, S Wurie, L Burns, C Harmston, C Evans, CU Nwokolo, B Singh, RP Arasaradnam

Gut Jul 2017, 66 (Suppl 2) A30-A31; DOI: 10.1136/gutjnl-2017-314472.57
PTU-063 Faecal calprotectin – time to re-draw the line
RN Patel, P Gyawali, V Clough, Z Khatami

Gut Jul 2017, 66 (Suppl 2) A81-A82; DOI: 10.1136/gutjnl-2017-314472.158
PTH-072 An exploratory study of the impact of primary care faecal calprotectin testing on referrals to secondary care
N Taylor, H Everitt, S Latter, K Burrill, E Efrem, F Cummings

Gut Jul 2017, 66 (Suppl 2) A242; DOI: 10.1136/gutjnl-2017-314472.471
PTH-095 Persistently elevated faecal calprotectin in the first 12 months of crohn’s diagnosis predicts the need for surgery: a nested case-control study
P Pavlidis, A Cockroft, LM Choong, P Ravdas, L Medcalf, J Tumova, S Chatu, R Spirajaskanthan, A Kent, G Chung-Faye, P Dubois, BH Hayee

Gut Jul 2017, 66 (Suppl 2) A253; DOI: 10.1136/gutjnl-2017-314472.494

Log in using your username and password

Main menu

Log in using your username and password

You are here

FAECAL CALPROTECTIN